J.P. Peyrat

1.1k total citations
30 papers, 970 citations indexed

About

J.P. Peyrat is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, J.P. Peyrat has authored 30 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Genetics. Recurrent topics in J.P. Peyrat's work include Growth Hormone and Insulin-like Growth Factors (12 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Estrogen and related hormone effects (5 papers). J.P. Peyrat is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (12 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Estrogen and related hormone effects (5 papers). J.P. Peyrat collaborates with scholars based in France, Morocco and Austria. J.P. Peyrat's co-authors include Jacques Bonneterre, Jean Djiane, A Demaille, R. Beuscart, Karine Laud, Isabelle Gourdou, Laurence Pessemesse, Louis Hornez, Françoise Révillion and Mohamed Hebbar and has published in prestigious journals such as Annals of the New York Academy of Sciences, British Journal of Cancer and Annals of Oncology.

In The Last Decade

J.P. Peyrat

30 papers receiving 945 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.P. Peyrat France 15 511 344 289 218 207 30 970
Kazutaka Haraguchi Japan 17 483 0.9× 145 0.4× 508 1.8× 134 0.6× 143 0.7× 46 1.1k
Ling-Mei Wang United States 9 876 1.7× 262 0.8× 269 0.9× 133 0.6× 77 0.4× 9 1.3k
Kazuyasu Ohta Japan 8 341 0.7× 161 0.5× 338 1.2× 132 0.6× 79 0.4× 9 628
Lawrence Lansing United States 7 397 0.8× 135 0.4× 399 1.4× 77 0.4× 123 0.6× 10 886
Yoshiaki Onodera Japan 23 772 1.5× 285 0.8× 102 0.4× 260 1.2× 201 1.0× 57 1.3k
Wen Y. Chen United States 16 353 0.7× 171 0.5× 570 2.0× 194 0.9× 211 1.0× 28 843
B L Seely United States 15 827 1.6× 181 0.5× 312 1.1× 160 0.7× 68 0.3× 17 1.0k
C. Andrew Powers United States 16 288 0.6× 138 0.4× 246 0.9× 137 0.6× 268 1.3× 36 849
Daniel L. Altschuler United States 22 1.0k 2.0× 294 0.9× 331 1.1× 115 0.5× 181 0.9× 35 1.6k
Wendy W. Hwang‐Verslues Taiwan 17 818 1.6× 546 1.6× 48 0.2× 424 1.9× 96 0.5× 22 1.4k

Countries citing papers authored by J.P. Peyrat

Since Specialization
Citations

This map shows the geographic impact of J.P. Peyrat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Peyrat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Peyrat more than expected).

Fields of papers citing papers by J.P. Peyrat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Peyrat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Peyrat. The network helps show where J.P. Peyrat may publish in the future.

Co-authorship network of co-authors of J.P. Peyrat

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Peyrat. A scholar is included among the top collaborators of J.P. Peyrat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Peyrat. J.P. Peyrat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Révillion, Françoise, et al.. (2007). ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis. Annals of Oncology. 19(1). 73–80. 118 indexed citations
2.
Hebbar, Mohamed, Marie‐Ange Krzewinski‐Recchi, Anne Harduin‐Lepers, et al.. (2003). Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients. The International Journal of Biological Markers. 18(2). 116–122. 28 indexed citations
3.
Laud, Karine, Isabelle Gourdou, Laurence Pessemesse, J.P. Peyrat, & Jean Djiane. (2002). Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Molecular and Cellular Endocrinology. 188(1-2). 219–226. 164 indexed citations
4.
Descamps, Simon, Valérie Pawlowski, Mohamed Hebbar, et al.. (2001). Expression of nerve growth factor receptors and their prognostic value in human breast cancer. HAL (Le Centre pour la Communication Scientifique Directe). 91 indexed citations
5.
Laud, Karine, Louis Hornez, Isabelle Gourdou, et al.. (2001). Expression of BRCA1 gene in ewe mammary epithelial cells during pregnancy: regulation by growth hormone and steroid hormones. European Journal of Endocrinology. 145(6). 763–770. 10 indexed citations
6.
Blanckaert, Vincent, Mohamed Hebbar, M M Louchez, et al.. (1998). Basic fibroblast growth factor receptors and their prognostic value in human breast cancer.. PubMed. 4(12). 2939–47. 44 indexed citations
7.
Peyrat, J.P., Philippe Vennin, Louis Hornez, et al.. (1998). Germline BRCA1 mutations in patients from 84 families with breast and/or ovarian cancers in northern France. European Journal of Cancer Prevention. 7. S7–S12. 5 indexed citations
8.
Widschwendter, Martin, Andreas Widschwendter, Thomas Welte, et al.. (1998). Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitro. British Journal of Cancer. 79(2). 204–210. 12 indexed citations
9.
Adenis, Antoine, J.P. Peyrat, B Hecquet, et al.. (1995). Type I insulin-like growth factor receptors in human colorectal cancer. European Journal of Cancer. 31(1). 50–55. 20 indexed citations
10.
Peyrat, J.P., et al.. (1995). Presence of the two growth hormone receptor messenger RNA isoforms in human breast cancer.. PubMed. 6(4). 477–83. 25 indexed citations
11.
Bonneterre, Jacques, et al.. (1993). Bromocriptin (B) and lanreotide (L) in advanced breast cancer: A phase II study. European Journal of Cancer. 29. S84–S84. 3 indexed citations
12.
Peyrat, J.P. & Jacques Bonneterre. (1992). Type 1 IGF receptor in human breast diseases. Breast Cancer Research and Treatment. 22(1). 59–67. 104 indexed citations
13.
Jammes, Hélène, J.P. Peyrat, Eunmi Ban, et al.. (1992). Insulin-like growth factor 1 receptors in human breast tumour: Localisation and quantification by histo-autoradiographic analysis. British Journal of Cancer. 66(2). 248–253. 23 indexed citations
14.
Bonneterre, Jacques, J.P. Peyrat, & A Demaille. (1990). Growth factors and oncogenes in human solid tumors: clinical aspects. Biomedicine & Pharmacotherapy. 44(1). 25–34. 4 indexed citations
15.
Peyrat, J.P., Jacques Bonneterre, P Vennin, et al.. (1990). Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors. The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 823–827. 41 indexed citations
16.
Bonneterre, Jacques, J.P. Peyrat, R. Beuscart, & A Demaille. (1990). Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer.. PubMed. 50(21). 6931–5. 118 indexed citations
17.
Bonneterre, Jacques, J.P. Peyrat, R. Beuscart, & A Demaille. (1990). Prolactin (PRL) and breast cancer. European Journal of Cancer and Clinical Oncology. 26(2). 154–154. 1 indexed citations
18.
Leroy‐Martin, B. & J.P. Peyrat. (1989). Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D).. PubMed. 9(3). 631–6. 8 indexed citations
19.
Peyrat, J.P., Jacques Bonneterre, Jean Djiane, et al.. (1987). IGF1 receptors (IGF1-R) in 72 primary human breast cancer. Relation with estradiol and progesterone receptors (ER, PgR). European Journal of Cancer and Clinical Oncology. 23(11). 1788–1788. 1 indexed citations
20.
Vandewalle, B., et al.. (1985). Transferrin receptors in cultured breast cancer cells. Journal of Cancer Research and Clinical Oncology. 110(1). 71–76. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazutaka Haraguchi Breakdown of academic impact, for papers by Ling-Mei Wang Breakdown of academic impact, for papers by Kazuyasu Ohta Breakdown of academic impact, for papers by Lawrence Lansing Breakdown of academic impact, for papers by Yoshiaki Onodera Breakdown of academic impact, for papers by Wen Y. Chen Breakdown of academic impact, for papers by B L Seely Breakdown of academic impact, for papers by C. Andrew Powers Breakdown of academic impact, for papers by Daniel L. Altschuler Breakdown of academic impact, for papers by Wendy W. Hwang‐Verslues
Rankless by CCL
2026